搜尋結果
Taking multiple medications? You may need to scale back
Straits Times· 3 日前Polypharmacy increases people’s risk of experiencing severe side effects and drug interactions. Read more at straitstimes.com.
How Love, Forgiveness & Compassion Maximize AI Project Decision Value
Forbes· 3 日前Maximum AI value will be unlocked when humans and AI work together, not by automating people ...
How Drug Companies Stifle Competition With ‘Product Hopping’
Forbes· 3 日前Actavis had spent that sum to acquire Forest and its portfolio of pharmaceutical products. ...
Senate AI Working Group’s Road Map Leaves Many Unanswered Questions
Forbes· 3 日前After a yearlong period of hearings and expert consultations, the Senate AI Working Group ...
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk
Reuters· 4 日前In a whistleblower complaint filed on Monday, Valisure said GSK violated the federal False ...
UnitedHealth's unit to launch new drug pricing model next year
Reuters· 4 日前, opens new tab said on Monday its unit OptumRx would offer a new pricing model, starting next year, to help manage insurers ...
GSK Faces Whistleblower Suit From Lab That Exposed Zantac Risk
Bloomberg· 4 日前GSK Plc is facing a whistleblower lawsuit that could potentially cost it billions of dollars ...
Shares of Hims & Hers Health surge 27% after startup says it will offer GLP-1 injections
CNBC· 4 日前Digital pharmacy startup Hims & Hers Health is introducing access to compounded GLP-1 weight ...
Hims & Hers Stock Hits 3-Year High After Announcing $199 Weight-Loss Alternative To Wegovy
Forbes· 4 日前Shares of telehealth company Hims & Hers Health closed at a three-year high Monday after the ...
ALI HEALTH, JOINTOWN PHARMACEUTICAL Collaborate on Digital Transformation of Prescription
AASTOCKS.com· 5 日前AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities ...